5:30 PM
 | 
May 23, 2014
 |  BC Extra  |  Company News

Pharmstandard, Millhouse to gain stake in Russian biosimilar play

Pharmstandard OJSC (RTS:PHST; LSE:PHST) and Russian investment firm Millhouse LLC are acquiring a combined 70% stake in Russian biosimilar company Biocad CJSC (St. Petersburg, Russia). Pharmstandard will acquire a 20%...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >